The ASPHO 2015 Distinguished Career Award Goes to Dr. Winfred C. Wang, MD
USE OF LEVOFLOXACIN PROPHYLAXIS TO REDUCE INFECTIONS IN PATIENTS WITH AML
INHIBITION OF LEUKEMIA-CELL CALCINEURIN PROMOTES T CELL-MEDIATED SUPPRESSION OF LEUKEMOGENESIS
CHIMERIC ANTIGEN RECEPTOR (CAR)-MODIFIED T CELLS INDUCE DURABLE REMISSIONS IN CHILDREN WITH RELAPSED/REFRACTORY ALL
AML IMMUNOTHERAPY WITH CD123-ENGAGER T CELLS
ROLE OF KLF4 IN T CELL LEUKEMIA
RESISTANCE TO CYTARABINE IN ACUTE MYELOID LEUKEMIA BY EXOSOMES DERIVED FROM PRIMARY BONE MARROW STROMAL CELLS.
A NOVEL MECHANISM OF FETAL HEMOGLOBIN INDUCTION VIA IKAROS SUPPRESSION IN SICKLE CELL ANEMIA BY THE IMID COMPOUND POMALIDOMIDE
EFFICACY OF RED CELL EXCHANGE, PARTIAL MANUAL EXCHANGE, AND SIMPLE TRANSFUSION, CONCURRENTLY WITH IRON CHELATION THERAPY, IN REDUCING IRON OVERLOAD IN CHRONICALLY TRANSFUSED SICKLE CELL PATIENTS
COPY NUMBER NEUTRAL LOSS OF HETEROZYGOSITY OF CHROMOSOME ARM 6p IN ACQUIRED APLASTIC ANEMIA: FREQUENCY, CLONAL EVOLUTION AND CLINICAL SIGNIFICANCE
EXTENDED GENETIC TESTING OF ALPS AND ALPS LIKE DISORDERS REVEALS NOVEL DISORDERS OF IMMUNE DYSFUNCTION, INCLUDING DEFECTS IN CTLA4, PI3KCD, AND STAT3 GENES
THE CRM1 NUCLEAR EXPORT RECEPTOR ACTIVATES HOXA GENE EXPRESSION IN SEVERAL LEUKEMIA MODELS
RNA NANOPARTICLE VACCINES FACILITATE AND SUSTAIN ADOPTIVE CELLULAR THERAPY TARGETING PEDIATRIC INTRACRANIAL MALIGNANCIES
CLINICAL AND BIOLOGIC PREDICTORS OF MYCN AMPLIFICATION IN NEUROBLASTOMA: A REPORT FROM THE INTERNATIONAL NEUROBLASTOMA RISK GROUP (INRG) PROJECT
NORADRENALINE TRANSPORTER GENE TRANSFER VIA ONCOLYTIC VIROTHERAPY ENHANCES 131I-mIBG UPTAKE: A NOVEL TARGETED APPROACH TO HIGH-RISK NEUROBLASTOMA
MULTISPECIFIC T CELLS FOR THE TREATMENT OF HIGH GRADE GLIOMAS
PEDIATRIC PERSONALIZED ONCOGENOMICS (PEDSPOG) -INITIAL OUTCOMES
SEXUAL DYSFUNCTION IN YOUNG ADULT SURVIVORS OF CHILDHOOD CANCER
INTERIM ANALYSIS OF THE ASPHO MENTORING PROGRAM
HEMO-MILESTONES TOOL INCREASES ASSESSMENT OF SELF-MANAGEMENT COMPETENCY AND PLAN FOR SKILL BUILDING IN PATIENTS WITH HEMOPHILIA
THE NORTH AMERICAN SHWACHMAN-DIAMOND SYNDROME REGISTRY: Five YEARS OF FOLLOW-UP
THE GENOMIC LANDSCAPE OF PEDIATRIC ACUTE MEGAKARYOBLASTIC LEUKEMIA
MATRIX METALLOPROTEINASE-14 INHIBITION AS A NOVEL THERAPEUTIC APPROACH FOR B-ALL AND AML: POISONING THE LEUKEMIA NICHE
MRX2843, A NOVEL DUAL MERTK & FLT3 INHIBITOR WITH ACTIVITY AGAINST RESISTANCE-CONFERRING FLT3 MUTATIONS IN ACUTE MYELOID LEUKEMIA
MAP2K1 MUTATIONS IN LANGERHANS CELL HISTIOCYTOSIS (LCH) AND JUVENILE XANTHOGRANULOMA (JXG) RESULT IN CONSTITUTIVE ACTIVATION OF MEK AND RESPOND TO MEK INHIBITORS
THROMBIN INDUCED APOPTOSIS IS PROTEASE ACTIVATED RECEPTOR (PAR)-3/-4 DEPENDENT IN HUMAN PODOCYTES AND PAR-1/-4 DEPENDENT IN RAT PODOCYTES
EVALUATION OF ANGIOGENIC CYTOKINES ASSOCIATED WITH THE REACTIVE THROMBOCYTOSIS CAUSED BY IRON DEFICIENCY ANEMIA
ERYTHROID CELLS FROM DIAMOND BLACKFAN ANEMIA (DBA) PATIENTS WITH GATA1 AND RIBOSOMAL PROTEIN (RP) MUTATIONS SHOW MARKED DIFFERENCES IN RNA EXPRESSION
CHEMOTHERAPY-ONLY PREPARATIVE REGIMEN FOR ALTERNATIVE DONOR HEMATOPOIETIC CELL TRANSPLANTATION (HCT) FOR PATIENTS WITH FANCONI ANEMIA (FA): RESULTS OF A MULTI-INSTITUTIONAL STUDY
DECREASING TIME TO ANTIBIOTIC DELIVERY FOR FEBRILE IMMUNOCOMPROMISED PATIENTS IN A PEDIATRIC EMERGENCY DEPARTMENT
ROLE OF PLATELETS IN THE DEVELOPMENT OF GRAFT VERSUS HOST DISEASE
FEBRILE NEUTROPENIA AND SICKLE CELL PAIN CRISIS: ACUTE MANAGEMENT PLANNING
FACTORS DETERMINING OUTCOME OF HEMATOPOIETIC CELL TRANSPLANTATION IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA AT KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER, RIYADH, SAUDI ARABIA
OUTCOMES RESILIENCE AFTER SYSTEM STRESS: A RAPID-CYCLE RESPONSE TO MITIGATE THE IMPACT OF SYSTEM STRESS ON PRIMARY BLOOD STREAM INFECTIONS
TCRαβ AND CD19 DEPLETED HAPLOIDENTICAL STEM CELL TRANSPLANT IN HOYERAAL - HREIDARSSON SYNDROME, A USEFUL STRATEGY IN A HIGH RISK GROUP.
PILOT TEST OF A DECISION RULE AND IMPLEMENTATION OF AN OUTPATIENT MANAGEMENT STRATEGY FOR LOW RISK PEDIATRIC FEVER AND NEUTROPENIA
A RETROSPECTIVE STUDY ANALYZING THE ADVERSE EFFECTS AND EFFICACY OF IV PENTAMIDINE FOR PNEUMOCYSTIS JIROVECI PNEUMONIA PROPHYLAXIS IN PEDATRIC ALLOGENEIC STEM CELL TRANSPLANT PATIENTS
BIOMARKERS IN FEBRILE NEUTROPENIA
INCIDENCE AND OUTCOMES OF PEDIATRIC HEMATOPOIETIC TRANSPLANT PATIENTS DIAGNOSED WITH THE NEW CLASSIFICATION MUCOSAL BARRIER INJURY LABORATORY-CONFIRMED BLOODSTREAM INFECTIONS (MBI-LCBI)
THE AMBULATORY CENTRAL LINE ASSOCIATED BLOOD STREAM INFECTIONS BURDEN IN A PEDIATRIC HEMATOLOGY-ONCOLOGY POPULATION
PROSPECTIVE PILOT STUDY EVALUATING SLEEP DISRUPTION IN CHILDREN AND YOUNG ADULTS UNDERGOING STEM CELL TRANSPLANTATION
A TARGETED QUALITY IMPROVEMENT PROJECT TO INCREASE INFLUENZA VACCINATION RATES IN ACTIVE PEDIATRIC ONCOLOGY AND STEM CELL TRANSPLANT PATIENTS
THE UTILITY OF BRONCHOALVEOLAR LAVAGE IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
PSYCHOLOGICAL DISTRESS AMONG PEDIATRIC CANCER CAREGIVERS
OUTCOMES OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PEDIATRIC PATIENTS WITH MYELODYSPLASTIC SYNDROMES DUE TO MUTATIONS IN GATA2.
The Educational Passport for hematology/oncology fellows: A pilot project
GENETICALLY SELECTED DONOR CURES FANCONI ANEMIA
MEASURING PEDIATRIC HEMATOLOGY-ONCOLOGY FELLOWS' SKILLS IN HUMANISM AND PROFESSIONALISM: A NOVEL ASSESSMENT INSTRUMENT
SUCCESSFUL BONE MARROW TRANSPLANTATION WITH A REDUCED INTENSITY CONDITIONING REGIMEN FOR HYPEREOSINOPHILIC SYNDROME ASSOCIATED WITH MYELODYSPLASTIC SYNDROME
IMPROVING THE CURRICULUM IN THE PEDIATRIC HEMATOLOGY AND ONCOLOGY RESIDENCY PROGRAM
SINGLE INSTITUTION EXPERIENCE USING ALLOGENEIC HSCT TO TREAT PEDIATRIC NK/T CELL LYMPHOMA
ANNUAL BLOOD PRODUCTS CONSENT FOR INPATIENT HEMATOLOGY, ONCOLOGY, AND BONE MARROW TRANSPLANT PATIENT: ADVANCED QUALITY IMPROVEMENT PROJECT
NOVEL APPROACH TO A RARE DISORDER OF GLYCOLYSIS “TRIOSEPHOSPHATE ISOMERASE I (TPI1) DEFICIENCY” - FIRST REPORTED BONE MARROW TRANSPLANT (BMT)
USING A WIZARD OF OZ APPROACH TO STUDY THE EFFECTS OF EHRs ON CLINICAL WORKFLOW IN A PEDIATRIC ONCOLOGY CLINIC
EVANS SYNDROME FOLLOWING MATCHED SIBLING ALLOGENEIC STEM CELL TRANSPLANT IN PEDIATRIC PATIENT
NEEDS ASSESSMENT STUDY FOR COMPLIANCE RATE IN PATIENTS WITH MALIGNANCIES AT A SEMI-URBAN SETTING OF INDIA
A PROSPECTIVE ANALYSIS OF IMMUNE RECONSTITUTION IN PEDIATRIC PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
PEDIATRIC ONCOLOGY CLINICAL CARE: A NOVEL MODEL TO ACHIEVE BETTER CONTINUITY OF CARE IN A MEDIUM SIZED PROGRAM
AN ACCURATE AND RAPID COLOR-BASED VISUAL POINT-OF-CARE ASSAY FOR THE DETECTION OF SEVERE ANEMIA IN LOW RESOURCE SETTING
BREAKING TRADITION: COMPLEMENTARY ROLE OF TRADITIONAL MEDICINE IN NATIONAL CANCER CONTROL PLANS GLOBALLY
EFFICACY AND SAFETY OF INTRAVENOUS FERRIC CARBOXYMALTOSE IN CHILDREN WITH IRON DEFICIENCY ANEMIA UNRESPONSIVE TO ORAL IRON THERAPY
DEVELOPING A MOBILE HEALTH APPLICATION: INHERENT TECHNOLOGICAL, PROGRAMMATIC, AND DEVELOPMENT ISSUES FROM THE PROVIDER'S PERSPECTIVE
CLINICAL PRESENTATION AND OUTCOME OF AUTOIMMUNE HEMOLYTIC ANEMIA IN THE PEDIATRIC POPULATION; EXPERIENCE AT MAYO CLINIC
COMPARISON OF CLINICAL RESPIRATORY SCORE AND PATIENT OUTCOMES WITH SIMPLE VERSUS RED CELL EXCHANGE TRANSFUSION IN ACUTE CHEST SYNDROME
DEFECTS IN OSTEO-CHONDROGENIC LINEAGE COMMITMENT IN MOUSE MODELS OF DIAMOND BLACKFAN ANEMIA: POTENTIAL ROLE IN ONCOGENESIS
THE EARLY IMPLEMENTATION OF HYDROXYUREA IN SICKLE CELL DISEASE PATIENTS WITH CONDITIONALLY ABNORMAL TRANSCRANIAL DOPPLER ULTRASOUNDS TO DECREASE ADVERSE SEQUELAE AND PREVENT NEED FOR CHRONIC TRANSFUSIONS
DELETERIOUS CONSEQUENCES OF DIAMOND BLACKFAN ANEMIA (DBA) ON REPRODUCTIVE HEALTH AND PREGNANCY OUTCOMES: A REPORT FROM THE DIAMOND BLACKFAN ANEMIA REGISTRY (DBAR)
BARRIERS TO IMPROVING ANALGESIA FOR VASO-OCCLUSIVE PAIN CRISES IN PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE
GENOTYPE-PHENOTYPE CORRELATION OF PHYSICAL ABNORMALITIES IN PATIENTS WITH FANCONI ANEMIA
NO MEAN FEAT: PREDICTING RECURRENT SPLENIC SEQUESTRATION IN PEDIATRIC SICKLE CELL PATIENTS
REPLICATIVE STRESS LEADS TO PRENATAL STEM CELL ATTRITION IN FANCONI ANEMIA
PROGRESSION OF CEREBRAL VASCULOPATHY IN CHILDREN WITH SICKLE CELL DISEASE UNDERGOING CHRONIC TRANSFUSION THERAPY FOR PRIMARY AND SECONDARY STROKE PREVENTION
NEUTROPENIA IN INFANCY: A NORMAL PROCESS?
SIGNIFICANT VARIATION IN SERUM CREATININE LEVELS AMONG PEDIATRIC PATIENTS WITH DIFFERENT SICKLE CELL GENOTYPES
IDENTIFICATION AND CLINICAL CHARACTERIZATION OF CHILDREN WITH BENIGN NEUTROPENIA
INITIAL VALIDATION OF A RAPID PAPER-BASED TEST IN SCREENING NEWBORNS FOR SICKLE CELL DISEASE
MULTIDISCIPLINARY CARE FOR COMPLEX DISORDER: SHWACHMAN-DIAMOND SYNDROME (SBDS) AS A SINGLE-CENTER EXPERIENCE AND EXAMPLE
RED BLOOD CELL ALLOIMMUNIZATION IN SICKLE CELL DISEASE IN THE ERA OF EXTENDED RED CELL TYPING: A SINGLE-CENTER EXPERIENCE
DEVELOPMENT OF A NOVEL IN VITRO THREE DIMENTIONAL OSTEOBLASTIC NICHE MODEL TO STUDY HEMATOPOIETIC STEM CELL MIGRATION AND ENGRAFTMENT
SERIAL ECHOCARDIOGRAM FINDINGS IN CHILDREN WITH SICKLE CELL DISEASE
TSLP DIFFERENTIALLY TARGETS MULTI-LYMPHOID PROGENITORS AND B LINEAGE CELLS IN NORMAL HUMAN HEMATOPOIESIS
MISSED OPPORTUNITY? A COMPARISON OF ONLINE COVERAGE OF SICKLE CELL DISEASE AND CYSTIC FIBROSIS
EDUCATING TRAINEES ABOUT BLOOD PRODUCTS: IMPACT OF A FORMAL TEACHING MODULE IN THE TRANSFUSION SERVICE
COMPARISON OF CLINICAL OUTCOMES BETWEEN ADULT AND PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE (SCD): 3-YEAR FOLLOW-UP IN A PROSPECTIVE, LONGITUDINAL, NONINTERVENTIONAL REGISTRY TRIAL
EFFECTIVENESS OF PLATELET TRANSFUSION GUIDELINES IN A PEDIATRIC TERTIARY CARE SETTING
FACTORS ASSOCIATED WITH HYDROXYUREA MEDICATION ADHERENCE IN CHILDREN WITH SICKLE CELL DISEASE
PHARMACOKINETIC AND COST CONSIDERATIONS FOR TRANSITION TO EXTENDED HALF-LIFE (EHL) FACTOR VIII AND IX PRODUCTS
OPTIMIZATION OF PAIN MANAGEMENT STRATEGIES IN CHILDREN WITH SICKLE CELL DISEASE AND VASO-OCCLUSIVE CRISES
TESTING THE KNOWLEDGE OF HEMOPHILIA A AND INHIBITORS IN HEALTH CARE PROVIDERS
RETROSPECTIVE STUDY OF EFFECTIVENESS OF SEPSIS PROTOCOL FOR EARLY INITIATION OF TREATMENT FOR PATIENTS WITH SICKLE CELL DISEASE
HEMOPHILIA HEARTS: CARDIOVASCULAR RISK ASSESSMENT IN CHILDREN WITH HEMOPHILIA
THE USE OF MOBILE TECHNOLOGY TO PROVIDE INTENSIVE TRAINING FOR ORAL CHELATION MANAGEMENT IN PEDIATRIC SICKLE CELL DISEASE AND BETA-THALASSEMIA
SAFETY AND EFFICACY OF LONG-TERM OPEN-LABEL DOSING OF ROMIPLOSTIM, A THROMBOPOIETIN (TPO) − RECEPTOR AGONIST, IN THROMBOCYTOPENIC PEDIATRIC PATIENTS WITH IMMUNE THROMBOCYTOPENIA (ITP) IN AN EXTENSION STUDY
REALIZING EFFECTIVENESS ACROSS CONTINENTS WITH HYDROXYUREA: THE REACH TRIAL
A Pilot Study to Assess Health-Related Quality of Life (HRQoL) in Older Children and Adolescents with Primary Immune Thrombocytopenia (ITP)
TARGETING MICROPARTICLE PRIMING OF NEUTROPHILS DURING SICKLE CELL VASO-OCCLUSIVE PAIN CRISES
THROMBOELASTOGRAPHY TESTING IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH PEG-ASPARAGINASE
DIFFUSE MYOCARDIAL FIBROSIS IS A NOVEL MECHANISM OF CARDIOMYOPATHY IN SICKLE CELL DISEASE
Hematologic Characteristics and Management of Neonatal Stroke
PRIMARY CARE-SPECIALTY PARTNERSHIPS TO IMPROVE OUTCOMES IN SICKLE CELL TRANSITION CARE
EVALUATION OF THE SAFETY AND EFFICACY OF A HOME MONITORING PROGRAM FOR CHILDREN RECEIVING CHRONIC WARFARIN THERAPY
INFLUENCE of APOL1 POLYMORPHISMS ON ALBUMINURIA IN CHILDREN WITH SICKLE CELL ANEMIA
CONTINUOUS RECOMBINANT HUMAN ANTITHROMBIN INFUSION TO OVERCOME HEPARIN RESISTANCE IN NEONATES AND YOUNG INFANTS WITH LIFE-THREATENING THROMBOSIS
EFFECTS OF GENETIC POLYMORPHISMS ON LEUKOCYTE AND NEUTROPHIL COUNTS ON CHILDREN WITH SICKLE CELL ANEMIA
TREATMENT OUTCOMES IN PEDIATRIC PATIENTS WITH PULMONARY EMBOLISM USING LOW DOSE TISSUE PLASMINOGEN ACTIVATOR THERAPY
DEVELOPMENT OF QUALITY MARKERS FOR THE TRANSITION FROM PEDIATRIC TO ADULT CARE IN SICKLE CELL DISEASE FROM THE PERSPECTIVE OF ADULT PROVIDERS USING A MODIFIED DELPHI METHOD
USE OF SIROLIMUS IN VASCULAR ANOMALIES DURING INFANCY
ENHANCED ANGIOGENESIS AND HEME-OXYGENASE-1 ACTIVITY IS ASSOCIATED WITH MELANOMA GROWTH IN SICKLE CELL DISEASE MICE
Treatment Strategies for Airway Hemangiomas
INFLUENCE OF HYDROXYUREA ON PICA IN SICKLE CELL DISEASE
ORAL RAPAMYCIN USE IN PTEN HAMARTOMA SYNDOMES AND COMPLEX VASCULAR ANAOMLIES
ALTERED VENTRICULAR GLOBAL LONGITUDINAL STRAIN IN CHILDREN WITH SICKLE CELL DISEASE
PHLEBOTOMY TO TREAT IRON OVERLOAD IN CHILDHOOD CANCER SURVIVORS
CONTRAST ENHANCED ULTRASOUND IMAGING TO DETECT ABNORMALITIES OF MICROVASCULAR BLOOD FLOW IN MURINE MODELS OF SICKLE CELL DISEASE
OVARIAN TISSUE CRYOPRESERVATION IS AN OPTION FOR FEMALE OF ALL AGES AT RISK OF INFERTILITY FROM GONADOTOXIC THERAPIES
PREVALANCE OF ELEVATED TRICUSPID REGURGITATION JET VELOCITY IN PATIENTS WITH SICKLING AND NON-SICKLING HEMOLYTIC ANEMIAS
TOBACCO USE BEHAVIORS AMONG SIBLINGS OF CHILDHOOD CANCER SURVIVORS: A REPORT FROM THE CHILDHOOD CANCER SURVIVOR STUDY
BMI AND THE ASSOCIATION WITH VASO-OCCLUSIVE CRISES IN PEDIATRIC SICKLE CELL DISEASE
FATIGUE IN CHILDHOOD CANCER SURVIVORS: A REPORT FROM PROJECT REACH
HYDROXYUREA FOR NON-TRANSFUSION-DEPENDENT β-THALASSEMIA: A META-ANALYSIS
ARTERIAL STIFFNESS IN CHILDHOOD CANCER SURVIVORS
HYDROXYUREA FOR β-THALASSEMIA MAJOR: A META-ANALYSIS
LOW PREVALENCE OF IRON OVERLOAD IN SURVIVORS OF CHILDHOOD CANCER
DIAGNOSIS OF UNSTABLE ALPHA CHAIN HEMOGLOBINOPATHIES IN THALASSEMIA INTERMEDIA
EARLY HIGH-ACUITY HEALTHCARE UTILIZATION AMONG CHILDHOOD CANCER SURVIVORS
PREDICTORS OF LIVER DISEASE IN PATIENTS WITH HOMOZYGOUS THALASSEMIA MAJOR ON BLOOD TRANSFUSION THERAPY
A RARE CASE OF IDIOPATHIC CD4 LYMPHOCYTOPENIA WITH SECONDARY ANTIPHOSPHOLIPID ANTIBODY SYNDROME IN A YOUNG ADULT WITH EXCELLENT RESPONSE TO IMMUNOSUPPRESSIVE THERAPY WITH MYCOPHENOLATE MOFETIL
EFFECT OF COMBINATION OF IRON CHELATION THERAPY IN HOMOZYGOUS BETA THALASSEMIA CHILDREN WITH HEAVY IRON OVERLOAD
AN EXTREMELY PALE TODDLER: TRANSIENT ERYTHROBLASTOPENIA OF CHILDHOOD IN A PATIENT WITH CONCOMITANT SICKLE CELL TRAIT DISEASE
SUCCESSFUL MANAGEMENT OF BLUE RUBBER BLEB NEVUS SYNDROME (BRBNS) WITH SIROLIMUS
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: NOT JUST APLASTIC ANEMIA - CASE REPORT
MULTIFOCAL EPITHELIOID HEMANGIOENDOTHELIOMA OF THE LIVER AND LUNGS: TREATMENT WITH SIROLIMUS
A CASE OF IRON-REFRACTORY IRON DEFICIENCY ANEMIA: A NOVEL MUTATION C.1807G > C (EXON 15) OF TMPRSS6
A CASE REPORT ON THE USE OF PROPRANOLOL AS A SUCCESSFUL TREATMENT FOR PEDIATRIC VENOLYMPHATIC MALFORMATIONS(VLMS)
PORTOMESENTERIC VENOUS THROMBOSIS AS FIRST PRESENTATION OF THROMBOPHILIC DISORDERS IN ADOLESCENTS
RESPONSE OF BLUE RUBBER BLEB NEVUS SYNDROME TO SIROLIMUS TREATMENT: A SINGLE INSTITUTION EXPERIENCE
HEMATOLOGIC CONCERNS ASSOCIATED WITH GOAT'S MILK ANEMIA
VISCERAL LEISHMANIASIS ASSOCIATED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: CASE REPORT
AUTOIMMUNE THROMBOCYTOPENIA IN A PATIENT WITH HUNTER SYNDROME: SHOULD IDURONATE-2-SULFATASE REPLACEMENT THERAPY STILL BE CONSIDERED?
IS THERE AN AGREEMENT FOR POST-TRANSPLANT HEMOPHAGOCYTIC LYMPHOCYTOSIS DIAGNOSIS?
HERMANSKY PUDLAK SYNDROME: A CASE SERIES AND NOVEL MUTATION
ANAKINRA IN THE TREATMENT OF EXTRACUTANEOUS JUVENILE XANTHOGRANULOMA
SUCCESSFUL TREATMENT OF CONGENITAL TTP WITH KOATE-DVI, AN INTERMEDIATE PURITY PLASMA-DERIVED FACTOR VIII CONCENTRATE
HEPATOMEGALY WITH CHOLANGITIC ABSCESSES WITH FAILURE TO THRIVE - A RARE CASE OF ISOLATED LIVER LCH AT PRESENTATION
METHOTREXATE PRECIPITATES VASO-OCCLUSIVE CRISES IN AN ADOLESCENT WITH SICKLE CELL DISEASE AND JUVENILE IDIOPATHIC ARTHRITIS
GAMMA HEAVY CHAIN DISEASE IN ASSOCIATION WITH POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE: A CASE REPORT AND LITERATURE REVIEW
CELLCEPT TREATMENT IN RESISTANT ITP AND AUTOIMMUNE CYTOPENIA
Near Fatal Presentation of Neuro-degenerative Langerhans Cell Histiocytosis
ITP AS A RARE EXTRA-INTESTINAL MANIFESTION OF ULCERATIVE COLITIS
LYMPHOMATOID GRANULOMATOSIS FOLLOWING PRIMARY EBV INFECTION IN A 14 YEAR OLD WITH TRISOMY 8 MOSAICISM
LABORATORY DIAGNOSIS OF BERNARD-SOULIER SYNDROME: USEFULNESS OF PARAMETERS FROM THE SYSMEX-XE SERIES OF AUTOMATED CBC ANALYZERS
CONCOMITANT PRESENTATION OF HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE-LIKE LYMPHOMA IN A PRE-B-CELL ALL: AN UNUSUAL ASSOCIATION
MERCURY POISONING AS AN UNUSUAL CAUSE OF IMMUNE THROMBOCYTOPENIC PURPURA
ESTHESIONEUROBLASTOMA: A VERY RARE CAUSE OF A NASAL MASS IN AN 18-YEAR OLD FEMALE
FAMILIAL ERYTHROCYTOSIS AND HYPOXIA INDUCIBLE FACTOR 2-ALPHA
SYNCHRONOUS TYPE Ir AND TYPE II PLEUROPULMONARY BLASTOMA IN A CHILD WITHOUT DICER1 SYNDROME
ANTI-MALARIAL INDUCED METHEMOGLOBINEMIA IN A CASE OF G6PD DEFICIENCY WITH MALARIA
DICER-1 SHOWING ITS UGLY FACE AGAIN. A NOVEL DICER1 MUTATION IDENTIFIED IN A FEMALE WITH AN UNDIFFERENTIATED RENAL SARCOMA WITH CYSTIC NEPHROMA BACKGROUND
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME WITH CARDIAC THROMBUS IN A FOUR YEAR OLD GIRL, A CASE REPORT AND REVIEW OF THE LITERATURE
RAPID AND COMPLETE RESPONSE OF INFLAMMATORY MYOFIBROBLASTIC TUMOR OF BLADDER TO CELECOXIB
SPONTANEOUS SPLENIC RUPTURE IN A NEONATE WITH SEVERE HEMOPHILIA A AND HEMOLYTIC DISEASE OF THE NEWBORN
LATE METASTATIC RETINOBLASTOMA PRESENTING WITH SPINAL CORD COMPRESSION
BILATERAL NON-PROLIFERATIVE SICKLE CELL RETINOPATHY (NPSR) CAUSING PROFOUND VISION LOSS IN AN 8 YEAR OLD CHILD WITH SICKLE CELL DISEASE (SCD)
A NON-GERMINONATOUS GERM CELL TUMOR IN A 15 YEAR OLD WITH SICKLE CELL DISEASE
SEVERE COMBINED IMMUNODEFICIENCY (SCID) PRESENTING AS NEONATAL APLASTIC ANEMIA
OVARY PRESERVATION IN THE TREATMENT OF CHILDHOOD MEIGS SYNDROME: A CASE REPORT AND LITERATURE REVIEW
PULMONARY COMPLICATIONS AND FUNCTIONAL ASSESSMENT OF LUNG FIBROBLASTS IN A PEDIATRIC PATIENT WITH DYSKERATOSIS CONGENITA
CONGENITAL TRANSFORMATION OF SACROCOCCYGEAL TERATOMA TO MALIGNANT CENTRAL PRIMITIVE NEUROECTODERMAL TUMOR: A CASE REPORT
SUCCESSFUL CATHETER-DIRECTED THROMBOLYSIS IN A PEDIATRIC PATIENT WITH KNOWN PROTEIN S DEFICIENCY
A REPORT OF A CHILD WITH A PITUITARY BLASTOMA AND DICER1 SYNDROME
SEVERE ANEMIA SECONDARY TO CONCOMITANT OCCURRENCE OF STOMATOCYTOSIS AND HEREDITARY SPHEROCYTOSIS (HS) IN A PATIENT WITH PARENTERAL NUTRITION-ASSOCIATED LIVER DISEASE (PNALD)
A REPORT OF OSTEOSARCOMA IN A CHILD WITH TRISOMY 21
DASATINIB INDUCED CHYLOTHORAX AND NEPHROTIC SYNDROME IN A PEDIATRIC PATIENT
DIFFICULT DIAGNOSIS AND TREATMENT OF AN ADOLESCENT RENAL TUMOR
PEDIATRIC ACUTE PROMYELOCYTIC LEUKEMIA PRESENTING AS ISCHEMIC STROKE: A COAGULATION CONUNDRUM
LONG-TERM USE OF SIROLIMUS IN PTEN HAMARTOMA TUMOR SYNDROME – CASE SERIES
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME AND CEREBRAL SINUS THROMBOSIS IN A CASE OF PEDIATRIC B CELL ALL
EPITHELIOID SARCOMA WITH PLACENTAL METASTASIS IN A PREGNANT ADOLESCENT FEMALE
EBV LYMPHOPROLIFERATIVE DISEASE OF THE CNS IN A CHILD WITH LOW RISK PRE-B CELL ACUTE LYMPHOBLASTIC LEUKEMIA
A RARE PRESENTATION OF SARCOMA
SEVERE, PERSISTENT AND FATAL T-CELL IMMUNODEFICIENCY POST INFANTILE LEUKEMIA THERAPY
HEPATOBLASTOMA ASSOCIATED WITH CAT EYE SYNDROME AND CONGENITAL UROGENITAL ANOMALIES
HISTIOCYTIC SARCOMA, JUVENILE XANTHOGRANULOMA, NEUROFIBROMAS AND B-ALL IN A PATIENT WITH CONSTITUTIONAL HOMOZYGOUS DELETION WITHIN CDKN2A
TWO RARE CASES OF HEPATOCELLULAR MALIGNANT NEOPLASM (HMN) - NOT OTHERWISE SPECIFIED (NOS), A NEWLY RECOGNIZED PEDIATRIC CANCER
LARGE GRANULAR LYMPHOCYTE LEUKEMIA PRESENTING IN ADOLESCENCE
CASE REPORT: THE DIAGNOSIS AND TREATMENT OF PRIMARY MYELOFIBROSIS IN TWIN ADOLESCENTS
CASE REPORT: SUCCESSFUL CONCURRENT TREATMENT OF CHRONIC HEPATITIS B INFECTION IN PEDIATRIC B CELL ACUTE LYMPHOBLASTIC LEUKEMIA AND A ROLE FOR SCREENING OF HIGH RISK CARRIERS
SECONDARY VIP-SECRETION IN INTERMEDIATE RISK NEUROBLASTOMA
PTOSIS CAUSED BY LACRIMAL GLAND INFILTRATION AS A PRESENTING SIGN IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
CEREBRAL METASTASIS OF HEPATOBLASTOMA: WHAT IS THE BEST THERAPY?
ACUTE ERYTHROID LEUKEMIA AND PULMONARY FIBROSIS: A CASE REPORT AND REVIEW OF THE LITERATURE
A RARE CASE OF A TESTICULAR LEYDIG CELL TUMOR IN A 4-YEAR-OLD BOY WHO PRESENTED WITH ISOSEXUAL PRECOCIOUS PUBERTY AND A UNILATERAL TESTICULAR MASS
A COMMON PRESENTATION OF A VERY RARE PEDIATRIC ENTITY: T-CELL LARGE GRANULAR LYMPHOCYTIC LEUKEMIA IN A CHILD
ADRENAL INSUFFICIENCY IN PATIENTS WITH HIGH RISK NEUROBLASTOMA
CO-EXPRESSION OF MONOSOMY 7 AND CHROMOSOME 3 ABNORMALITY IN PEDIATRIC ACUTE MYELOID LEUKEMIA (AML) PRESENTING WITH CENTRAL DIABETES INSIPIDUS (DI) IS RARE AND HAS A POOR PROGNOSIS
NOVEL ASSOCIATION OF FAMILIAL TESTICULAR GERM CELL TUMOR AND AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE WITH PKD1 MUTATION
EXTENSIVE PERINEAL AND PERIANAL CONDYLOMA ACUMINATA IN A CHILD UNDERGOING THERAPY FOR ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
ATYPICAL PRESENTATION OF CHEMOTHERAPY INDUCED ACRAL ERYTHEMA (CIAE) AFTER TREATMENT WITH HIGH DOSE METHOTREXATE (HD MTX)
IDENTIFICATION, MANAGEMENT AND OUTCOMES OF ACUTE LEUKEMIAS OF AMBIGUOUS LINEAGE - A CASE SERIES
SEVERE RADIATION RECALL IN TISSUE AND LUNG AFTER HIGH DOSE STEREOTACTIC RADIOSURGERY IN A CHILD
SINUSIODAL OBSTUCTION SYNDROME FOLLOWING LOW-DOSE 6-MERCAPTOPURINE THERAPY
A NOVEL MUTATION IN THE HARS GENE IN A PATIENT WITH INFANTILE MYOFIBROMATOSIS
T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AND HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS DIAGNOSED AT PRESENTATION IN A 15 YEAR OLD MALE
NEUROBLASTOMA PRESENTS AS CHRONIC DIARRHEA IN A PEDIATRIC PATIENT
F317i MUTATION-ASSOCIATED NILOTINIB RESISTANCE IN A CHILD WITH CML; A FIRST REPORT
MEDICAL MANAGEMENT OFFERS SYMPTOMATIC RELIEF WITH VERY LOW DOSE SIROLIMUS IN A PATIENT WITH PTEN HAMARTOMA SYNDROME INELIGIBLE FOR INTERVENTIONAL PROCEDURES
AN UNUSUAL CASE OF EPSTEIN-BARR VIRUS (EBV) MASQUERADING AS LYMPHOMA IN A 16 YEAR OLD YOUNG MAN: A CASE REPORT
COMPLETE RESOLUTION OF VOCAL CORD PARALYSIS AFTER MEDULOBLASTOMA TREATMENT
FOCAL SEGMENTAL GLOMERULOSCLEROSIS IN ASSOCIATION WITH HODGKIN LYMPHOMA WITH COMPLETE RENAL IMPROVEMENT ON CHEMOTHERAPY: CASE REPORT AND LITERATURE REVIEW
USE OF mTOR INHIBITOR IN THE TREATMENT OF SUB EPENDYMAL GIANT CELL ASTROCYTOMA IN A PATIENT WITHOUT TUBEROUS SCLEROSIS
EBV-NEGATIVE DONOR-DERIVED POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD) DEVELOPING 5 YEARS AFTER CORD BLOOD TRANSPLANT.
BRAIN TUMORS IN CHILDREN WITH SICKLE CELL DISEASE: TREATMENT CHALLENGES FOR YOUNG CHILDREN WITH CNS TUMORS AT RISK FOR CEREBRAL VASCULOPATHY
MEDIASTINAL GRAY ZONE LYMPHOMA: AN UNCOMMON PEDIATRIC ENTITY
EXTENDED BEVACIZUMAB AND IRINOTECAN THERAPY IN PEDIATRIC PILOMYXOID ASTROCYTOMA
PROLONGED COMPLETE RESPONSE IN A PEDIATRIC PATIENT WITH PRIMARY PERIPHERAL T-CELL LYMPHOMA OF THE CENTRAL NERVOUS SYSTEM
CRANIOPHARYNGIOMA PRESENTING AS ACUTE PSYCHOSIS: FIRST REPORTED CASE IN A PEDIATRIC PATIENT
RARE CENTRAL NERVOUS SYSTEM INVOLVEMENT PRESENTING IN TWO PEDIATRIC PATIENTS WITH POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER PATHOLOGIC SUBTYPE PLASMABLASTIC LARGE B-CELL LYMPHOMA
SUCCESSFUL USE OF PROTON BEAM THERAPY IN A 13-YEAR OLD MALE WITH BASAL GANGLIA GERMINOMA
THE FIRST AND SECOND GENERATION TYROSINE KINASE INHIBITORS ROLE IN THE PHILADELPHIA POSITIVE CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
CASE SERIES OF PEDIATRIC GLIOBLASTOMA MULTIFORME
EXERCISE PRACTICES, PREFERENCES, AND BARRIERS IN THE PEDIATRIC ONCOLOGY POPULATION
A NOVEL APPROACH TO INVESTIGATING THE PATHOGENESIS OF ONCOGENIC TRANSLOCATIONS IN INFANT LEUKEMIA USING ENGINEERED NUCLEASES
A COMPARISON OF ACUTE LYMPHOBLASTIC LEUKEMIA IN THE US AND MEXICO AT TWO SINGLE INSTITUTIONS
REGULATION OF PI3K PATHWAY BY IKAROS AND CASEIN KINASE II (CK2) IN PEDIATRIC LEUKEMIA
CORRELATION BETWEEN BONE MARROW SPICULARITY AND MINIMAL RESIDUAL DISEASE AMONG CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
WEANED PIG MODEL OF ASPARAGINASE-INDUCED PANCREATITIS
ACUTE NEUROLOGIC DETERIORATION IN CHILDREN ON CHEMOTHERAPY FOR LEUKEMIA - TIMING, ETIOLOGY AND OUTCOME
THE WEANED PIG AS A MODEL FOR ASPARAGINASE INFUSION REACTIONS
MEASURING LEVELS OF STRESS IN PARENTS OF CHILDREN WITH CANCER WHO HAVE RECENTLY COMPLETED TREATMENT
EPIGENETIC REGULATION OF CELLULAR PROLIFERATION IN ACUTE LYMPHOBLASTIC LEUKEMIA BY IKAROS AND HDAC1
RISK FACTORS FOR CENTRAL LINE ASSOCIATED BLOOD STREAM INFECTIONS IN CHILDREN WITH ACUTE MYELOGENOUS LEUKEMIA: A SINGLE INSTITUTION REPORT
CYCLIN DEPENDENT KINASE 5 AS A MARKER OF DISEASE ACTIVITY IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
PATIENT CONTROLLED ANALGESIA AT THE END OF LIFE IN A PEDIATRIC ONCOLOGY INSTITUTION
HISTONE PROFILING IN LEUKEMIA USING LC-MS/MS
ROLE OF ASPARAGINASE SERUM MONITORING IN MANAGING HYPERSENSITIVITY REACTIONS TO PEGASPARGASE IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
INTERFERENCE WITH BONE MARROW STROMA DERIVED CXCL12 INCREASES APOPTOSIS IN ALL CELLS AND ENHANCES ANTILEUKEMIA EFFECTS OF CHEMOTHERAPY DRUGS
INTRAVENOUS IMMUNOGLOBULIN ADMINISTRATION DURING MAINTENANCE CHEMOTHERAPY IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA: EVALUATION OF INDICATION, USE, AND EFFICACY
ROLE OF WNT/ß-CATENIN PATHWAY IN THERAPY RELATED MYELOID NEOPLASMS (T-MDS/AML) WITH 5Q DELETION: A NEW THERAPEUTIC TARGET
L-ASPARAGINASE INDIVIDUALIZED DOSING AND SWITCHING IN ALL: AN NNT ANALYSIS
GENERATING POTENT CHIMERIC ANTIGEN RECEPTOR T CELLS USING INTERLEUKIN 15 RECEPTOR ALPHA SIGNAL AS A CO-STIMULATORY DOMAIN
PEDIATRIC-INSPIRED VERSUS HYPERCVAD PROTOCOLS FOR PHILADELPHIA-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) IN ADOLESCENTS AND YOUNG ADULTS (AYA): AN NNT ANALYSIS
MLL-REARRANGED ALL CELLS RELEASE HIGH MOBILITY GROUP BOX 1, AN IMMUNOLOGIC DANGER SIGNAL THAT SUPPRESSES MACROPHAGE FUNCTION AND CAR T CELL KILLING IN AN IN VITRO MODEL OF THE TUMOR MICROENVIRONMENT
BORTEZOMIB, DEXAMETHASONE, MITOXANTRONE AND VINORELBINE (BDMV): A HIGHLY ACTIVE REINDUCTION REGIMEN FOR CHILDREN WITH RELAPSED ALL AND ASPARAGINASE INTOLERANCE
MODIFYING ENGAGER T-CELLS TO EXPRESS COSTIMULATORY MOLECULES FOR THE IMMUNOTHERAPY OF CD19 POSITIVE MALIGANCIES
EXCELLENT OVERALL SURVIVAL (100%) IN TURKISH CHILDREN WITH STANDART RISK ACUTE LYMPHOBLASTIC LEUKEMIA
THE FEASIBILITY OF QUANTITATIVE SENSORY TESTING IN PEDIATRIC ONCOLOGY PATIENTS TREATED WITH VINCRISTINE
CAN ETOPOSIDE BE AVOIDED IN SOME PATIENTS WITH HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS?
MANAGEMENT OF PEDIATRIC PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA: SINGLE CENTER EXPERIENCE IN VENEZUELA
CLINICAL & LABORATORY PROFILE OF HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN CHILDREN FROM A TERTIARY-CARE PEDIATRIC CENTRE IN INDIA
DELAYED METHOTREXATE CLEARANCE IN CHILDREN, CAN WE PREDICT IT?
VIRAL SURVEILLANCE USING PCR DURING TREATMENT OF AML AND ALL NOT INCLUDING HEMATOPOIETIC STEM CELL TRANSPLANT
PRIMARY BONE LYMPHOMA IN ADOLESCENTS AND YOUNG ADULTS TREATED WITH R-CHOP CHEMOTHERAPY
CHARACTERIZATION, COST, AND OUTCOME OF BACTEREMIA IN CHILDREN WITH FEBRILE NEUTROPENIA AT A CHILDREN'S HOSPITAL
THROMBOTIC COMPLICATIONS OF PERIPHERALLY INSERTED CENTRAL CATHETERS DURING INDUCTION THERAPY FOR CHILDREN WITH ALL: A RETROSPECTIVE SINGLE INSTITUTION STUDY
Hodgkin Lymphoma Associated Paraneoplastic Syndromes
IDENTIFICATION OF RISK FACTORS FOR HYPERSENSITIVITY REACTIONS TO PEG-ASPARAGINASE IN PEDIATRIC PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
EFFECTS OF BODY MASS INDEX AT DIAGNOSIS ON RELAPSE RISK IN PEDIATRIC HODGKIN LYMPHOMA PATIENTS
A PILOT STUDY OF MITOXANTRONE IN COMBINATION WITH CLOFARABINE (MITCL) IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS (CAYA) WITH REFRACTORY/RELAPSED ACUTE LEUKEMIA
A NEW PERSPECTIVE ON NOTCH INHIBITION IN T-ALL: PRO-DIFFERENTIATION EFFECTS THAT SYNERGIZE WITH DEXAMETHASONE
CANINES AND CHILDHOOD CANCER: WHAT ARE THE EFFECTS OF ANIMAL-ASSISTED INTERVENTIONS FOR PEDIATRIC ONCOLOGY PATIENTS AND THEIR PARENTS?
RHABDOMYOSARCOMA OF THE BREAST IN ADOLESCENT AND YOUNG ADULT (AYA) WOMEN (A CASE SERIES)
EVALUATION OF FAMILY FUNCTIONING HEALTH RELATED QUALITY OF LIFE (HRQOL) IN CHILDREN WITH CANCER ON ACTIVE TREATMENT
COMPARISON OF CLINICAL CHARACTERISTICS AND OUTCOMES BETWEEN PEDIATRIC AND ADULT PATIENTS WITH DESMOPLASTIC SMALL ROUND CELL TUMOR
IDENTIFICATION OF THE GENOMIC MUTATION THAT CAUSES A RARE INHERITED FORM OF KIDNEY CANCER
PRECLINICAL EFFICACY STUDY WITH BI-FUNCTIONAL SHORT-HAIRPIN RNA (bi-shRNA) FOR EWING SARCOMA
DIFFERENTIAL EFFECTS OF MXI1 AND MXI0 ON N-MYC-DEPENDENT NEUROBLASTOMA PATHOGENESIS AND CHEMOSENSITIVITY
TAXOTERE, AVASTIN, GEMCITABINE “TAG” CHEMOTHERAPY FOR HIGH RISK RELAPSED AYA SARCOMA PATIENTS.
MULTIMODALITY TREATMENT OF PEDIATRIC ESTHESIONEUROBLASTOMA
PATTERNS OF FAILURE AND OPTIMAL RADIOTHERAPY TARGET VOLUMES IN PRIMARY INTRADURAL EXTRAMEDULLARY EWING SARCOMA
EPIGENETIC THERAPIES IN PRECLINICAL MODELS OF NEUROBLASTOMA
MYOFIBROMA IN INFANCY AND CHILDHOOD
THE IMPACT OF FGFR4 ARG388 ON NEUROBLASTOMA INCIDENCE, OUTCOME, AND RESPONSE TO TREATMENT
HSP27 AS A POTENTIAL REGULATOR OF GEMCITABINE-INDUCED AUTOPHAGY IN OSTEOSARCOMA CELLS
UBE4B LEVELS ARE CORRELATED WITH NEUROBLASTOMA PATIENT OUTCOMES AND TUMOR DIFFERENTIATION
SUCCESSFUL CHEMOTHERAPY FOR PEDIATRIC PATIENTS WITH INFANTILE FIBROSARCOMA
WITHAFERIN A AS A NOVEL DIFFERENTIATING AGENT FOR TREATMENT OF NEUROBLASTOMA
A NOVEL CpG ISLAND-FOCUSED ANALYSIS OF GENOME-WIDE METHYLATION PROFILING DATA IDENTIFIES EPIGENETICALLY DYSREGULATED GENES IN OSTEOSARCOMAS
DFMO INHIBITS NEUROSPHERE FORMATION AND TUMOR INITIATION IN NEUROBLASTOMA
CHARACTERIZATION OF A NOVEL FUSION GENE, EML4-NTRK3, IN INFANTILE FIBROSARCOMA
RESPONSE AND RESISTANCE TO THE RECEPTOR TYROSINE KINASE INHIBITOR (TKI) VANDETANIB IN PEDIATRIC PATIENTS WITH MEDULLARY THYROID CARCINOMA (MTC)
USE OF FISH AND FLOW CYTOMETRY FOR THE DETECTION OF MINIMAL RESIDUAL DISEASE IN EWING SARCOMA
THE ROLE OF 18F- FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY (18F-FDG PET) IN PEDIATRIC MEDULLARY THYROID CARCINOMA (MTC)
ALVEOLAR SOFT PART SARCOMA IN CHILDREN: AN INSTITUTIONAL EXPERIENCE
MANAGEMENT OF CHILDHOOD BRONCHIAL CARCINOID TUMORS
SOLID TUMORS DURING INFANCY: A RETROSPECTIVE REVIEW OF CASES OVER AN 18-YEAR PERIOD IN A TERTIARY CENTER IN CENTRAL ILLINOIS
IDO-BASED IMMUNE CHECKPOINT BLOCKADE FOR PEDIATRIC BRAIN TUMORS: PRECLINICAL DATA AND CLINICAL TRIAL DESIGN
A PILOT STUDY COMPARING THE ADDITION OF OLANZAPINE OR APREPITANT IN AN ANTIEMETIC REGIMEN FOR HIGHLY EMETOGENIC CHEMOTHERAPY
DISRUPTED NEURONAL NETWORK ACTIVITIES IN GLIOBALSTOMA MULTIFORME
TRENDS IN END-OF-LIFE CARE IN PEDIATRIC HEMATOLOGY, ONCOLOGY, AND BONE MARROW TRANSPLANT PATIENTS
THE USE OF COMPLEMENTARY AND ALTERNATIVE MEDICINE (CAM) IN CHILDREN WITH BRAIN TUMORS
PHASE 1 EVALUATION OF EVEROLIMUS (MTOR INHIBITOR) IN COMBINATION WITH VANDETANIB (MULTIKINASE INHIBITOR OF EGFR, VEGFR, AND RET) OR VEMURAFENIB (BRAF INHIBITOR) IN CHILDREN AND ADOLESCENTS WITH ADVANCED CANCERS
OUTCOME OF PEDIATRIC PATIENTS WITH INTRASPINAL LOW-GRADE ASTROCYTOMAS
THE ROLE OF PET/CT VS BONE MARROW BIOPSY IN THE INITIAL EVALUATION OF BONE MARROW INFILTRATION IN VARIOUS PEDIATRIC SOLID TUMORS
SOX2 Expression in Pediatric Brain Tumors: A Potential New Target for Immunotherapy
THE GENETIC FINGERPRINT OF SUSCEPTIBILITY TO TRANSPLANT ASSOCIATED THROMBOTIC MICROANGIOPATHY
FAMILIAL HAPLOIDENTICAL (FHI) T-CELL DEPLETED (TCD) WITH T-CELL ADDBACK STEM CELL TRANSPLANTATION FOR PATIENTS WITH HIGH-RISK SICKLE CELL DISEASE (SCD) (IND 14359)
REDUCED INTENSITY CONDITIONING AND ALLOGENEIC STEM CELL TRANSPLANTATION (ALLOSCT) FOLLOWED BY TARGETED CONSOLIDATION IMMUNOTHERAPY WITH GEMTUZUMAB OZOGAMICIN (GO) IN CHILDREN AND ADOLESCENTS WITH CD33+ ACUTE MYELOID LEUKEMIA (AML)
ROLE OF NATURAL KILLER CELLS IN CONTROLLING EWING SARCOMA GROWTH
DEFIBROTIDE FOR THE TREATMENT OF SEVERE HEPATIC VENO-OCCLUSIVE DISEASE: A SUBGROUP ANALYSIS OF CLINICAL BENEFIT FOR PEDIATRIC PATIENTS AS DETERMINED BY NUMBER NEEDED TO TREAT (NNT) TO ACHIEVE COMPLETE RESPONSE AND TO IMPROVE SURVIVAL AT DAY 100 POST HEMATOPOIETIC STEM CELL TRANSPLANT
IMPLEMENTATION OF NEWBORN SCREENING FOR SEVERE COMBINED IMMUNODEFICIENCY IN OREGON
HISTOLOGIC FEATURES OF INTESTINAL THROMBOTIC MICROANGIOPATHY IN PATIENTS WITH HIGH RISK TMA AFTER HSCT
SURVIVAL OF PATIENTS WHO DEVELOP SOLID TUMORS FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION
TREATMENT OUTCOME OF SECONDARY AML AND MDS FOR CHILDREN AND YOUNG ADULTS FOLLOWING MYELOABLATIVE HEMATOPOIETIC STEM CELL TRANSPLANTATION
PROSPECTIVE ECHOCARDIOGRAPHIC SCREENING FOR CARDIAC DYSFUNCTION 100 DAYS AFTER STEM CELL TRANSPLANT IN CHILDREN AND YOUNG ADULTS
PEDIATRIC AND ADULT SUBGROUP RESULTS FROM AN ONGOING DEFIBROTIDE EXPANDED ACCESS PROGRAM IN THE US FOR PATIENTS WITH HEPATIC VENO-OCCLUSIVE DISEASE
HSCT OUTCOMES OF NATIVE AMERICANS WITH C-MPL MUTATIONS
DAY + 100 SURVIVAL ANALYSIS BY PRIOR HEMATOPOIETIC STEM CELL TRANSPLANT TYPE FROM AN ONGOING US STUDY OF DEFIBROTIDE FOR HEPATIC VENO-OCCLUSIVE DISEASE
EVALUATION AND ANALYSIS OF CAUSES OF EARLY READMISSION FOLLOWING UMBILICAL CORD BLOOD TRANSPLANTATION IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS
EARLY INTEGRATION OF PALLIATIVE CARE FOR CHILDREN AND ADOLESCENTS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
FACTORS ASSOCIATED WITH IMPROVED OUTCOMES AFTER SECOND HEMATOPOIETIC CELL TRANSPLANTATION IN PATIENTS WITH LEUKEMIA
PROSPECTIVE ECHOCARDIOGRAPHIC SCREENING FOR CARDIAC DYSFUNCTION 100 DAYS AFTER STEM CELL TRANSPLANT IN CHILDREN AND YOUNG ADULTS
LATE ENDOCRINE EFFECTS REMAIN PREVALENT DESPITE REDUCED INTENSITY CHEMOTHERAPY FOR HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN AND YOUNG ADULTS
ROR1 EXPRESSING NEUROBLASTOMA (NB), MEDULLOBLASTOMA (MB), AND EWING'S SARCOMA (ES) CAN BE EFFECTIVELY TARGETED WITH NK CELLS MODIFIED TO EXPRESS AN ANTI-ROR1 CHIMERIC ANTIGEN RECEPTOR (CAR)
VORICONAZOLE LEVELS INDICATE THAT PROPHYLAXIS DOSING MAY BE INSUFFICIENT FOR PROTECTION FROM FUNGUS IN PEDIATRIC STEM CELL RECIPIENTS
DONOR CELL ENGRAFTMENT EVALUATION IN CEREBROSPINAL FLUID BY SHORT TANDEM REPEAT ANALYSIS FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION
LOW INCIDENCE OF HEPATIC VENO OCCLUSIVE DISEASE (VOD) USING URSODEOXYHOLIC ACID (URSODIOL) AND HEPARIN PROPHYLAXIS IN PEDIATRIC HEMATOPOIETIC PROGENITOR CELL TRANSPLANT (HPCT) PATIENTS AT THE MEDICAL COLLEGE OF WISCONSIN
ADOLESCENT AGE CONFERS HIGH RISK OF GRADE III AND IV TOXICITIES IN THE 30 DAYS POST-ALLOGENEIC STEM CELL TRANSPLANT: A RETROSPECTIVE COHORT STUDY OF PEDIATRIC PATIENTS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION FOLLOWING BUSULFAN-BASED CONDITIONING FOR MALIGNANT AND NON-MALIGNANT DISEASES
THE EFFECT OF HEMODIALYSIS ON PLASMA DEFIBROTIDE PHARMACOKINETICS IN END-STAGE RENAL DISEASE PATIENTS: A PHASE 1, OPEN-LABEL STUDY
TACROLIMUS AND Q8H MYCOPHENOLATE MOFETIL (MMF) PROPHYLAXIS IN CHILDREN AND YOUNG ADULT (CAYA) RECIPIENTS OF ALLOGENEIC STEM CELL TRANSPLANTATION (ALLOSCT) RESULTS IN A VERY LOW INCIDENCE OF GRADE II-IV ACUTE GVHD (AGVHD)
HIGH DOSE CHEMO WITH STEM CELL RESCUE - A REVIEW OF ITS ROLE IN HIGH RISK SARCOMA
DEVELOPMENT OF POLYPS AS A LATE EFFECT AFTER HEMATOPOIETIC CELL TRANSPLANTATION (HCT)
IS THERE A ROLE? OUTCOMES IN RELAPSED/REFRACTORY WILMS' TUMOR AFTER HIGH DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC STEM CELL RESCUE
CT SCAN FREQUENTLY MISSES THE DIAGNOSIS OF POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME (PRES) AFTER STEM CELL TRANSPLANT
ELIMINATION OF THE POST-CRYOPRESERVATION WASH-STEP FOR UMBILICAL CORD UNIT TRANSPLANTATION
FAVORABLE OUTCOME OF VENO-OCCLUSIVE DISEASE WITH PREEMPTIVE AND AGGRESSIVE SUPPORTIVE CARE APPROACH FOLLOWING MYELOABLATIVE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN
THE PHARMACOKINETICS OF DEFIBROTIDE IN NONDIALYSIS PATIENTS WITH SEVERE/END-STAGE RENAL DISEASE PATIENTS COMPARED WITH HEALTHY MATCHING SUBJECTS: A PHASE 1, OPEN-LABEL STUDY
BIOPSY IDENTIFIES CD20+ B CELLS AS POTENTIAL MEDIATORS OF MINIMAL CHANGE NEPHROTIC SYNDROME CHRONIC GVHD
EOSINOPHILIC MENINGOENCEPHALITIS AND PROTRACTED COMA AS A PRESENTATION OF SEVERE QUISCENT CHRONIC GVHD IN A PATIENT AFTER HEMATOPOIETIC STEM CELL TRANSPLANT: CASE REPORT & REVIEW OF THE LITERATURE
HIGH DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION (HDC-ASCT) AND PHARMACOKINETIC ANALYSIS OF ULTRAFILTERABLE PLATINUM (UF-PT) DURING SLED IN A PATIENT WITH RECURRENT WILMS TUMOR AND RENAL FAILURE
ENDOCRINOPATHIESANDBONEHEALTHINFANCONIANEMIAPATIENTSFOLLOWINGHEMATOPOIETICCELLTRANSPLANTATION
A UNIQUE CASE OF CHRONIC GVHD WITH BRONCHIOLITIS OBLITERANS AND MEMBRANOUS BRONCHIAL WEBS AFTER BONE MARROW TRANSPLANT
DECLINE IN DONOR LYMPHOID CHIMERISM PRECEDING ACUTE MYELOID LEUKEMIA RELAPSE FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION CONDITIONED WITH BUSULFAN AND FLUDARABINE
NOVELTCELLDEPLETIONTECHNIQUESINPAEDIATRICHAPLOIDENTICALSTEMCELL TRANSPLANTS: THEMONEYEQUATION
THE SUCCESSFUL TREATMENT OF RECURRENT CNS DISEASE POST-HCT IN PATIENTS WITH HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
BENEFIT OF RECOMBINANT ACTIVATED FACTOR VII IN POST-ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION COMPLICATIONS WITH INTRACTABLE BLEEDING
SPONTANEOUS SUBARACHNOID HEMORRHAGE (SAH) DURING PERIPHERAL BLOOD PROGENITOR CELL (PBPC) INFUSION IN A PEDIATRIC PATIENT WITH ACUTE MYELOID LEUKEMIA (AML)